Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Cell & Gene Therapy Insights 2025; 11(2), 139

DOI: 10.18609/cgti.2025.017

Published: 7 May
FastFacts
Tia Harmon


Maintaining the quality and safety of cell and gene therapy (CGT) products requires precise control of environmental and metabolic conditions. This poster explores a live cell metabolic analyzer LiCellMo®*, which enables real-time monitoring of glucose and lactate levels, providing insights into metabolic processes in cells. The data obtained from LiCellMo can be used to evaluate the conditions of the cells, which can be applied in both metabolic research and CGT manufacturing.

NEW INTERACTIVE FORMAT
Listen to our expert speaker. Watch the video. Read the summary. Focus in on the data. Download the PDF. It has never been easier to quickly access the information you want. All in one place—at the click of a button.